The relationship between imipramine metabolism and the sparteine oxidation polymorphism.
Brøsen
K
K
Department of Clinical Pharmacology, Odense University.
D019389:Cytochrome P-450 CYP2D6; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D003647:Debrisoquin / Q000493:pharmacokinetics; D006801:Humans; D007099:Imipramine / Q000493:pharmacokinetics*; D007527:Isoenzymes / Q000235:genetics*; D008862:Microsomes, Liver / Q000201:enzymology; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000235:genetics*; D011110:Polymorphism, Genetic; D013034:Sparteine / Q000493:pharmacokinetics
D007527:Isoenzymes; D013034:Sparteine; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; D019389:Cytochrome P-450 CYP2D6; D007099:Imipramine; D003647:Debrisoquin